A caution by the Food and Drug Administration about the potentially life-threatening effects of Johnson & Johnson's Ortho Evra contraceptive patch has fanned the flames of what could become nationwide litigation. Suits claim that patch users have suffered strokes, heart attacks and even death as a result of blood clotting caused by heightened estrogen levels. Web sites are publicizing the FDA directive and the litigation options available -- and federal suits are popping up around the country.
FDA Notice About Contraceptive Patch Sparks Suits
New Jersey Law Journal
December 5, 2005